Clinical Trial Update: The Impact of Free Fatty Acid (FFA-) Suppression on Myocardial Lipids and Function in Patients With Type 2 Diabetes [Phase 2, Phase 3]

View source ↗

Summary

The document reports results from a Phase 2/3 clinical trial evaluating whether suppression of free fatty acids affects myocardial lipids and heart function in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Snippet

Sponsor: Medical University of Vienna | Conditions: Type 2 Diabetes | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2017-04-04